Ethylene-vinyl acetate (EVA) was used in tandem with high-resolution mass spectrometry (HRMS) because it was non-invasive and non-damaging to three letters written in the second half of the 15th century by Vlad III of Wallachia.
More than 500 years ago, rulers known as voivodes governed a set of regions which have since become modern-day Romania. Moldavia and Transylvania were among these, but in a third, Wallachia, perhaps the most famous historical voivode was Vlad III, also known as Vlad the Impaler or, in reference to his father having been made a member of the Order of the Dragon, Vlad Dracula. In 1897, Irish author Bram Stoker shifted the home of a namesake vampiric count to neighboring Transylvania and forever immortalized Vlad III, in the eyes of many literary scholars, in the novel Dracula.
But what might any of this have to do with separation science? Three letters written by Vlad III, two preserved for half a millennium in the archives of the city of Sibiu, Romania, and the other restored in that country’s capital, Bucharest, sometime in the 20th century were analyzed in a study published in Analytical Chemistry. The study, based at the University of Catania in Sicily, Italy, applied ethylene-vinyl acetate (EVA) technology to these three letters, written to the citizens of Sibiu and signed Vlad Dracula, “prince of the Transalpine regions,” characterizing the peptides and proteins contained therein with high-resolution mass spectrometry (HRMS) (1).
The EVA technology as described by the researchers in this experiment consists of a plastic film of ethylene-vinyl acetate studded with strong cation and anion exchangers, plus C18 (octyldecylsilane) and C8 (octyl) hydrophobic resins (1). The authors said this type of material can be applied to any surface with the goal of extracting proteins and small molecules, which are then able to be eluted and analyzed with MS. What this study revealed was not only a window into Vlad Dracula’s leadership and politics, but maybe most interestingly, his health and what influence it might have had on a future bloodthirsty fictional character.
The authors reported that this multifaceted approach resulted in the identification of approximately 100 ancient peptides in the letters which they said were of “certainly” human origin (1). In addition to that, they found some 2000 additional ones, among them bacteria, viruses, fungi, and insects, from the environment. Evidence from the likely “most prominent” ancient proteins among the potential hands that could have touched these letters points to Vlad himself, with the last of the letters dating to 1475 and Vlad dying either one or two years later. Late in his life, the authors said according to their findings, he may have suffered from inflammation of the respiratory tract or skin, but also a pathological condition called hemolacria—the phenomenon of shedding tears mixed with blood.
That may not read as dramatically as biting victims, but it does provide a tenuous link between the Draculas — with help from an MS-compatible technology that these authors hope will have just as long-lasting of an impact as Bram Stoker’s work has had on generations of readers.
(1) Pittalà, M. G. G.; Di Francesco, A.; Cucina, A.; et al. Count Dracula Resurrected: Proteomic Analysis of Vlad III the Impaler’s Documents by EVA Technology and Mass Spectrometry. Anal. Chem. 2023, 95 (34), 12732–12744. DOI: 10.1021/acs.analchem.3c01461
RAFA 2024 Highlights: Contemporary Food Contamination Analysis Using Chromatography
November 18th 2024A series of lectures focusing on emerging analytical techniques used to analyse food contamination took place on Wednesday 6 November 2024 at RAFA 2024 in Prague, Czech Republic. The session included new approaches for analysing per- and polyfluoroalkyl substances (PFAS), polychlorinated alkanes (PCAS), Mineral Oil Hydrocarbons (MOH), and short- and medium-chain chlorinated paraffins (SCCPs and MCCPs).
Advancing Bladder Cancer Research with Mass Spectrometry: A FeMS Interview with Marta Relvas-Santos
November 12th 2024LCGC International interviewed FeMS Empowerment Award winner Marta Relvas-Santos on her use of mass spectrometry to identify potential biomarkers and therapies for bladder cancer. She also shared insights on her work with FeMS and advice for fellow scientists.